| 1 | minimal invasive surgery medical | | | | | | | 3 | 0.44% |
| 2 | capabilities plastics machining plastic | | | | | | | 3 | 0.44% |
| 3 | invasive surgery medical implants | | | | | | | 3 | 0.44% |
| 4 | certifications locations leadership policies | | | | | | | 3 | 0.44% |
| 5 | surgery medical implants medical | | | | | | | 3 | 0.44% |
| 6 | medical molecular diagnostics medical | | | | | | | 3 | 0.44% |
| 7 | locations leadership policies careers | | | | | | | 3 | 0.44% |
| 8 | plastics machining plastic injection | | | | | | | 3 | 0.44% |
| 9 | biopharma medical molecular diagnostics | | | | | | | 3 | 0.44% |
| 10 | molecular diagnostics medical robotics | | | | | | | 2 | 0.29% |
| 11 | leadership policies careers rapid | | | | | | | 2 | 0.29% |
| 12 | interventional and structural heart | | | | | | | 2 | 0.29% |
| 13 | diagnostics medical robotics medical | | | | | | | 2 | 0.29% |
| 14 | mim metals binderjet micro | | | | | | | 2 | 0.29% |
| 15 | metals binderjet micro machining | | | | | | | 2 | 0.29% |
| 16 | binderjet micro machining laser | | | | | | | 2 | 0.29% |
| 17 | structural heart semi conductor | | | | | | | 2 | 0.29% |
| 18 | and structural heart semi | | | | | | | 2 | 0.29% |
| 19 | machining laser industries medical | | | | | | | 2 | 0.29% |
| 20 | molding mim metals binderjet | | | | | | | 2 | 0.29% |
| 21 | plastics additive manufacturing metals | | | | | | | 2 | 0.29% |
| 22 | additive manufacturing metals machining | | | | | | | 2 | 0.29% |
| 23 | medical implants medical orthotrauma | | | | | | | 2 | 0.29% |
| 24 | implants medical orthotrauma med | | | | | | | 2 | 0.29% |
| 25 | silicone plastics additive manufacturing | | | | | | | 2 | 0.29% |
| 26 | our clients” mark kemp | | | | | | | 1 | 0.15% |
| 27 | eptam parts are empowering | | | | | | | 1 | 0.15% |
| 28 | the area of succeeding | | | | | | | 1 | 0.15% |
| 29 | parts are empowering major | | | | | | | 1 | 0.15% |
| 30 | are empowering major scientific | | | | | | | 1 | 0.15% |
| 31 | clients” mark kemp – | | | | | | | 1 | 0.15% |
| 32 | team will be at | | | | | | | 1 | 0.15% |
| 33 | communities with our clients | | | | | | | 1 | 0.15% |
| 34 | breakthroughs launchingnew industries and | | | | | | | 1 | 0.15% |
| 35 | with our clients medicalbiopharma | | | | | | | 1 | 0.15% |
| 36 | clients medicalbiopharma diagnostics medical | | | | | | | 1 | 0.15% |
| 37 | our clients medicalbiopharma diagnostics | | | | | | | 1 | 0.15% |
| 38 | industries and building healthier | | | | | | | 1 | 0.15% |
| 39 | for our clients” mark | | | | | | | 1 | 0.15% |
| 40 | in the area of | | | | | | | 1 | 0.15% |